Prognosis in amyotrophic lateral sclerosis: A population-based study
Abstract
Background Accurate information on prognosis of ALS is useful to patients, families, and clinicians. Methods In a population-based study of ALS in western Washington, the authors assembled a cohort of 180 patients with incident ALS between 1990 and 1994. Information on potential prognostic factors was collected during an in-person interview. Patients also completed the Medical Outcomes Study Short Form 36 (SF-36). Vital status through December 1999 was known for all patients. Results Median survival was 32 months from onset of symptoms and 19 months from diagnosis. The 5-year survival after diagnosis was 7%. Older age and female sex were strongly associated with poor survival. In multivariable Cox proportional hazards regression models, factors significantly and independently associated with a worse prognosis included older age, any bulbar features at onset, shorter time from symptom onset to diagnosis, lack of a marital partner, and residence in King County. Recursive partitioning identified age, time from symptom onset to diagnosis, and marital status as the strongest predictors of survival. Good summary scores for physical health on the SF-36, but not for mental health, were significantly associated with longer survival than poor scores. Conclusion These findings are consistent with other population-based studies of ALS and confirm its pernicious nature. Older age, female sex, any bulbar features at onset, short time from symptom onset to diagnosis, lack of a marital partn…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The median survival time is well within the range reported by several population-based studies, which extends from 16 months to 28 months, with most studies reporting values between 19 and 23 months.
“it is well within the range reported by several population-based studies, which extends from 16 months (65;66) to 28 months (67), with most studies reporting values between 19 and 23 months (68–70).”
From Association of ALS with head injury, cigarette smoking and APOE genotypes (2010) · cites this paper as [70]
Cites
Survival in Amyotrophic Lateral Sclerosis: The Role of Psychological Factors
McDonald, E. R. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540130027010 · Cited by 193 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862 · see citing works
Effects of gender in amyotrophic lateral sclerosis
McCombe, P. A., & Henderson, R. D. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.11.010 · Cited by 379 · see citing works
ALSFRS-R score and its ratio: A useful predictor for ALS-progression
Kollewe, K., Mauss, U., Krampfl, K., Petri, S., Dengler, R., & Mohammadi, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.07.016 · Cited by 253 · see citing works
Association of ALS with head injury, cigarette smoking and APOE genotypes
Schmidt, S., Kwee, L. C., Allen, K. D., & Oddone, E. Z. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.01.011 · Cited by 117 · see citing works
Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
Ciregia, F., Urbani, A., & Palmisano, G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00276 · Cited by 110 · see citing works
Suicide among patients with amyotrophic lateral sclerosis
Fang, F., Valdimarsdóttir, U., Fürst, C. J., Hultman, C., Fall, K., Sparén, P., & Ye, W. (2008) · Brain · doi:10.1093/brain/awn161 · Cited by 100 · see citing works
Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
Grossman, M., Elman, L., McCluskey, L., McMillan, C. T., Boller, A., Powers, J., Rascovsky, K., Hu, W., Shaw, L., Irwin, D. J., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6064 · Cited by 94 · see citing works
Fitzgerald, K. C., O'Reilly, É. J., Fondell, E., Falcone, G. J., McCullough, M. L., Park, Y., Kolonel, L. N., & Ascherio, A. (2013) · Annals of Neurology · doi:10.1002/ana.23820 · Cited by 91 · see citing works
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy
Winter, Y., Schepelmann, K., Spottke, A. E., Claus, D., Grothe, C., Schröder, R., Heuss, D., Vielhaber, S., Tackenberg, B., Mylius, V., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5549-9 · Cited by 86 · see citing works
The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
Obrenovich, M., Jaworski, H., Tadimalla, T., Mistry, A., Sykes, L., Perry, G., & Bonomo, R. (2020) · Microorganisms · doi:10.3390/microorganisms8050784 · Cited by 62 · see citing works
Coping strategies as related to medical and demographic data in amyotrophic lateral sclerosis
Montel, S., Albertini, L., & Spitz, E. (2012) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01513.x · Cited by 61 · see citing works
Binazzi, A., Belli, S., Uccelli, R., Desiato, M. T., Talamanca, I. F., Antonini, G., Corsi, F., Scoppetta, C., Inghilleri, M., Pontieri, F., et al. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802382313 · Cited by 46 · see citing works
Occupational disruption: living with motor neurone disease
Brott, T., Hocking, C., & Paddy, A. (2007) · British Journal of Occupational Therapy · doi:10.1177/030802260707000107 · Cited by 22 · see citing works
- Authors
- del Aguila, M. A., Longstreth, W. T., McGuire, V., Koepsell, T. D., & van Belle, G.
- Affiliations
- From the Departments of Dental Public Health Sciences (Dr. del Aguila), Neurology (Dr. Longstreth), Epidemiology (Drs. del Aguila, Longstreth, McGuire, and Koepsell), Health Services (Dr. Koepsell), Environmental Health (Dr. van Belle), and Biostatistics (Dr. van Belle), University of Washington, Seattle.
- Venue
- Neurology
- Published
- 2003-03-11
- Volume
- 60
- Issue
- 5
- Pages
- 813-819
- ISSN
- 0028-3878
- 1526-632X
- Cited by
- 384
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review